{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T05:25:49Z","timestamp":1768886749436,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1475-2840-13-60","type":"journal-article","created":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T00:01:55Z","timestamp":1394755315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expression"],"prefix":"10.1186","volume":"13","author":[{"given":"Yuji","family":"Ishibashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho-ichi","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,13]]},"reference":[{"issue":"Suppl 3","key":"908_CR1","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.2337\/diab.45.3.S65","volume":"45","author":"H Vlassara","year":"1996","unstructured":"Vlassara H, Bucala R: Recent progress in advanced glycation and diabetic vascular disease: role of advanced glycation end product receptors. Diabetes. 1996, 45 (Suppl 3): S65-66.","journal-title":"Diabetes"},{"key":"908_CR2","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJM198805193182007","volume":"318","author":"M Brownlee","year":"1988","unstructured":"Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988, 318: 1315-1321. 10.1056\/NEJM198805193182007.","journal-title":"N Engl J Med"},{"key":"908_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12013-007-0021-x","volume":"48","author":"S Rahbar","year":"2007","unstructured":"Rahbar S: Novel inhibitors of glycation and AGE formation. Cell Biochem Biophys. 2007, 48: 147-157. 10.1007\/s12013-007-0021-x.","journal-title":"Cell Biochem Biophys"},{"key":"908_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1172\/JCI11771","volume":"108","author":"Y Yamamoto","year":"2001","unstructured":"Yamamoto Y, Kato I, Doi T, Yonekura H, Ohashi S, Takeuchi M, Watanabe T, Yamagishi S, Sakurai S, Takasawa S, Okamoto H, Yamamoto H: Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Invest. 2001, 108: 261-268. 10.1172\/JCI11771.","journal-title":"J Clin Invest"},{"key":"908_CR5","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/S0002-9440(10)63909-0","volume":"162","author":"TM Wendt","year":"2003","unstructured":"Wendt TM, Tanji N, Guo J, Kislinger TR, Qu W, Lu Y, Bucciarelli LG, Rong LL, Moser B, Markowitz GS, Stein G, Bierhaus A, Liliensiek B, Arnold B, Nawroth PP, Stern DM, D'Agati VD, Schmidt AM: RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol. 2003, 162: 1123-1137. 10.1016\/S0002-9440(10)63909-0.","journal-title":"Am J Pathol"},{"key":"908_CR6","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.2174\/1381612054367300","volume":"11","author":"S Yamagishi","year":"2005","unstructured":"Yamagishi S, Imaizumi T: Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy. Curr Pharm Des. 2005, 11: 2279-2299. 10.2174\/1381612054367300.","journal-title":"Curr Pharm Des"},{"key":"908_CR7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2174\/138161208783597416","volume":"14","author":"S Yamagishi","year":"2008","unstructured":"Yamagishi S, Nakamura K, Matsui T, Noda Y, Imaizumi T: Receptor for advanced glycation end products (RAGE): a novel therapeutic target for diabetic vascular complication. Curr Pharm Des. 2008, 14: 487-495. 10.2174\/138161208783597416.","journal-title":"Curr Pharm Des"},{"key":"908_CR8","doi-asserted-by":"publisher","first-page":"979","DOI":"10.2174\/138161208784139684","volume":"14","author":"K Jandeleit-Dahm","year":"2008","unstructured":"Jandeleit-Dahm K, Cooper ME: The role of AGEs in cardiovascular disease. Curr Pharm Des. 2008, 14: 979-986. 10.2174\/138161208784139684.","journal-title":"Curr Pharm Des"},{"key":"908_CR9","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.2337\/dc12-0087","volume":"35","author":"N Tahara","year":"2012","unstructured":"Tahara N, Yamagishi S, Takeuchi M, Honda A, Tahara A, Nitta Y, Kodama N, Mizoguchi M, Kaida H, Ishibashi M, Hayabuchi N, Matsui T, Imaizumi T: Positive association between serum level of glyceraldehyde-derived advanced glycation end products and vascular inflammation evaluated by [(18)F]fluorodeoxyglucose positron emission tomography. Diabetes Care. 2012, 35: 2618-2625. 10.2337\/dc12-0087.","journal-title":"Diabetes Care"},{"key":"908_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2174\/156720206775541804","volume":"3","author":"K Takenaka","year":"2006","unstructured":"Takenaka K, Yamagishi S, Matsui T, Nakamura K, Imaizumi T: Role of advanced glycation end products (AGEs) in thrombogenic abnormalities in diabetes. Curr Neurovasc Res. 2006, 3: 73-77. 10.2174\/156720206775541804.","journal-title":"Curr Neurovasc Res"},{"key":"908_CR11","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1177\/1479164110383723","volume":"7","author":"SH Alzahrani","year":"2010","unstructured":"Alzahrani SH, Ajjan RA: Coagulation and fibrinolysis in diabetes. Diab Vasc Dis Res. 2010, 7: 260-273. 10.1177\/1479164110383723.","journal-title":"Diab Vasc Dis Res"},{"key":"908_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.amjmed.2011.12.004","volume":"125","author":"G Piazza","year":"2012","unstructured":"Piazza G, Goldhaber SZ, Kroll A, Goldberg RJ, Emery C, Spencer FA: Venous thromboembolism in patients with diabetes mellitus. Am J Med. 2012, 125: 709-716. 10.1016\/j.amjmed.2011.12.004.","journal-title":"Am J Med"},{"key":"908_CR13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/dmrr.386","volume":"19","author":"I Klem","year":"2003","unstructured":"Klem I, Wehinger C, Schneider B, Hartl E, Finsterer J, St\u00f6llberger C: Diabetic atrial fibrillation patients: mortality and risk for stroke or embolism during a 10-year follow-up. Diabetes Metab Res Rev. 2003, 19: 320-328. 10.1002\/dmrr.386.","journal-title":"Diabetes Metab Res Rev"},{"key":"908_CR14","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s001250051089","volume":"41","author":"S Yamagishi","year":"1998","unstructured":"Yamagishi S, Fujimori H, Yonekura H, Yamamoto Y, Yamamoto H: Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells. Diabetologia. 1998, 41: 1435-1441. 10.1007\/s001250051089.","journal-title":"Diabetologia"},{"key":"908_CR15","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1161\/01.CIR.96.7.2262","volume":"96","author":"A Bierhaus","year":"1997","unstructured":"Bierhaus A, Illmer T, Kasper M, Luther T, Quehenberger P, Tritschler H, Wahl P, Ziegler R, M\u00fcller M, Nawroth PP: Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation. 1997, 96: 2262-2271. 10.1161\/01.CIR.96.7.2262.","journal-title":"Circulation"},{"key":"908_CR16","doi-asserted-by":"publisher","first-page":"20213","DOI":"10.1074\/jbc.M602110200","volume":"281","author":"S Yamagishi","year":"2006","unstructured":"Yamagishi S, Nakamura K, Matsui T, Inagaki Y, Takenaka K, Jinnouchi Y, Yoshida Y, Matsuura T, Narama I, Motomiya Y, Takeuchi M, Inoue H, Yoshimura A, Bucala R, Imaizumi T: Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression. J Biol Chem. 2006, 281: 20213-20220. 10.1074\/jbc.M602110200.","journal-title":"J Biol Chem"},{"key":"908_CR17","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1055\/s-2006-949529","volume":"38","author":"S Yamagishi","year":"2006","unstructured":"Yamagishi S, Kikuchi S, Nakamura K, Matsui T, Makino T, Norisugi O, Shimizu T, Inoue H, Imaizumi T: Pigment epithelium-derived factor (PEDF) blocks angiotensin II-induced T cell adhesion to endothelial cells by suppressing intercellular adhesion molecule-1. Horm Metab Res. 2006, 38: 546-548. 10.1055\/s-2006-949529.","journal-title":"Horm Metab Res"},{"key":"908_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ajpath.2012.09.016","volume":"182","author":"A Ojima","year":"2013","unstructured":"Ojima A, Ishibashi Y, Matsui T, Maeda S, Nishino Y, Takeuchi M, Fukami K, Yamagishi S: Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression. Am J Pathol. 2013, 182: 132-141. 10.1016\/j.ajpath.2012.09.016.","journal-title":"Am J Pathol"},{"key":"908_CR19","doi-asserted-by":"publisher","first-page":"8723","DOI":"10.1074\/jbc.272.13.8723","volume":"272","author":"Y Si","year":"1997","unstructured":"Si Y, Yonekura H, Yamamoto Y, Katsuno K, Sato F, Mita I, Ooka H, Satozawa N, Kawakami T, Nomura M, Yamamoto H: Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. J Biol Chem. 1997, 272: 8723-8730. 10.1074\/jbc.272.13.8723.","journal-title":"J Biol Chem"},{"key":"908_CR20","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1161\/hh1001.090840","volume":"88","author":"J Du","year":"2001","unstructured":"Du J, Brink M, Peng T, Mottironi B, Delafontaine P: Thrombin regulates insulin-like growth factor-1 receptor transcription in vascular smooth muscle: characterization of the signaling pathway. Circ Res. 2001, 88: 1044-1052. 10.1161\/hh1001.090840.","journal-title":"Circ Res"},{"key":"908_CR21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/cvr\/cvr220","volume":"92","author":"HJ Wei","year":"2011","unstructured":"Wei HJ, Li YH, Shi GY, Liu SL, Chang PC, Kuo CH, Wu HL: Thrombomodulin domains attenuate atherosclerosis by inhibiting thrombin-induced endothelial cell activation. Cardiovasc Res. 2011, 92: 317-327. 10.1093\/cvr\/cvr220.","journal-title":"Cardiovasc Res"},{"key":"908_CR22","doi-asserted-by":"publisher","first-page":"41432","DOI":"10.1074\/jbc.M110.158949","volume":"285","author":"PC Delekta","year":"2010","unstructured":"Delekta PC, Apel IJ, Gu S, Siu K, Hattori Y, McAllister-Lucas LM, Lucas PC: Thrombin-dependent NF-{kappa}B activation and monocyte\/endothelial adhesion are mediated by the CARMA3\u2009\u00b7\u2009Bcl10\u2009\u00b7\u2009MALT1 signalosome. J Biol Chem. 2010, 285: 41432-41442. 10.1074\/jbc.M110.158949.","journal-title":"J Biol Chem"},{"key":"908_CR23","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1161\/01.ATV.0000215638.53414.99","volume":"26","author":"Z Lin","year":"2006","unstructured":"Lin Z, Hamik A, Jain R, Kumar A, Jain MK: Kruppel-like factor 2 inhibits protease activated receptor-1 expression and thrombin-mediated endothelial activation. Arterioscler Thromb Vasc Biol. 2006, 26: 1185-1189. 10.1161\/01.ATV.0000215638.53414.99.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"908_CR24","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00441-005-1094-8","volume":"320","author":"S Yamagishi","year":"2005","unstructured":"Yamagishi S, Nakamura K, Ueda S, Kato S, Imaizumi T: Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF. Cell Tissue Res. 2005, 320: 437-445. 10.1007\/s00441-005-1094-8.","journal-title":"Cell Tissue Res"},{"key":"908_CR25","first-page":"147","volume":"29","author":"S Yamagishi","year":"2003","unstructured":"Yamagishi S, Inagaki Y, Kikuchi S: Nifedipine inhibits tumor necrosis factor-alpha-induced monocyte chemoattractant protein-1 overexpression by blocking NADPH oxidase-mediated reactive oxygen species generation. Drugs Exp Clin Res. 2003, 29: 147-152.","journal-title":"Drugs Exp Clin Res"},{"key":"908_CR26","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00125-002-1013-4","volume":"46","author":"Y Inagaki","year":"2003","unstructured":"Inagaki Y, Yamagishi S, Okamoto T, Takeuchi M, Amano S: Pigment epithelium-derived factor prevents advanced glycation end products-induced monocyte chemoattractant protein-1 production in microvascular endothelial cells by suppressing intracellular reactive oxygen species generation. Diabetologia. 2003, 46: 284-287.","journal-title":"Diabetologia"},{"key":"908_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000111152","volume":"40","author":"S Yamagishi","year":"2008","unstructured":"Yamagishi S, Matsui T, Nakamura K, Inoue H, Takeuchi M, Ueda S, Okuda S, Imaizumi T: Olmesartan blocks inflammatory reactions in endothelial cells evoked by advanced glycation end products by suppressing generation of reactive oxygen species. Ophthalmic Res. 2008, 40: 10-15. 10.1159\/000111152.","journal-title":"Ophthalmic Res"},{"key":"908_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1475-2840-12-125","volume":"12","author":"Y Ishibashi","year":"2013","unstructured":"Ishibashi Y, Matsui T, Maeda S, Higashimoto Y, Yamagishi S: Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate\/insulin-like growth factor II receptor. Cardiovasc Diabetol. 2013, 12: 125-10.1186\/1475-2840-12-125.","journal-title":"Cardiovasc Diabetol"},{"key":"908_CR29","doi-asserted-by":"publisher","first-page":"850","DOI":"10.2174\/092986608785203746","volume":"15","author":"S Yamagishi","year":"2008","unstructured":"Yamagishi S, Matsui T, Nakamura K, Takeuchi M, Inoue H: Telmisartan inhibits advanced glycation end products (AGEs)-elicited endothelial cell injury by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gammaactivation. Protein Pept Lett. 2008, 15: 850-853. 10.2174\/092986608785203746.","journal-title":"Protein Pept Lett"},{"key":"908_CR30","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.bbrc.2011.07.031","volume":"411","author":"D Kawanami","year":"2011","unstructured":"Kawanami D, Matoba K, Kanazawa Y, Ishizawa S, Yokota T, Utsunomiya K: Thrombin induces MCP-1 expression through Rho-kinase and subsequent p38MAPK\/NF-\u03baB signaling pathway activation in vascular endothelial cells. Biochem Biophys Res Commun. 2011, 411: 798-803. 10.1016\/j.bbrc.2011.07.031.","journal-title":"Biochem Biophys Res Commun"},{"key":"908_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1152\/physiolgenomics.00012.2009","volume":"38","author":"J Xue","year":"2009","unstructured":"Xue J, Thippegowda PB, Hu G, Bachmaier K, Christman JW, Malik AB, Tiruppathi C: NF-kappaB regulates thrombin-induced ICAM-1 gene expression in cooperation with NFAT by binding to the intronic NF-kappaB site in the ICAM-1 gene. Physiol Genomics. 2009, 38: 42-53. 10.1152\/physiolgenomics.00012.2009.","journal-title":"Physiol Genomics"},{"key":"908_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.cardiores.2005.05.029","volume":"68","author":"N Miho","year":"2005","unstructured":"Miho N, Ishida T, Kuwaba N, Ishida M, Shimote-Abe K, Tabuchi K, Oshima T, Yoshizumi M, Chayama K: Role of the JNK pathway in thrombin-induced ICAM-1 expression in endothelial cells. Cardiovasc Res. 2005, 68: 289-298. 10.1016\/j.cardiores.2005.05.029.","journal-title":"Cardiovasc Res"},{"key":"908_CR33","doi-asserted-by":"publisher","first-page":"5823","DOI":"10.4049\/jimmunol.174.9.5823","volume":"174","author":"M Minhajuddin","year":"2005","unstructured":"Minhajuddin M, Fazal F, Bijli KM, Amin MR, Rahman A: Inhibition of mammalian target of rapamycin potentiates thrombin-induced intercellular adhesion molecule-1 expression by accelerating and stabilizing NF-kappa B activation in endothelial cells. J Immunol. 2005, 174: 5823-5829.","journal-title":"J Immunol"},{"key":"908_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1475-2840-12-5","volume":"12","author":"Y Fukushima","year":"2013","unstructured":"Fukushima Y, Daida H, Morimoto T, Kasai T, Miyauchi K, Yamagishi S, Takeuchi M, Hiro T, Kimura T, Nakagawa Y, Yamagishi M, Ozaki Y, Matsuzaki M, JAPAN-ACS Investigators: Relationship between advanced glycation end products and plaque progression in patients with acute coronary syndrome: the JAPAN-ACS sub-study. Cardiovasc Diabetol. 2013, 12: 5-10.1186\/1475-2840-12-5.","journal-title":"Cardiovasc Diabetol"},{"key":"908_CR35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1540-8167.2007.01037.x","volume":"19","author":"T Kato","year":"2008","unstructured":"Kato T, Yamashita T, Sekiguchi A, Tsuneda T, Sagara K, Takamura M, Kaneko S, Aizawa T, Fu LT: AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat. J Cardiovasc Electrophysiol. 2008, 19: 415-420. 10.1111\/j.1540-8167.2007.01037.x.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"908_CR36","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ijcard.2011.05.072","volume":"157","author":"S Raposeiras-Roub\u00edn","year":"2012","unstructured":"Raposeiras-Roub\u00edn S, Rodi\u00f1o-Janeiro BK, Grigorian-Shamagian L, Seoane-Blanco A, Moure-Gonz\u00e1lez M, Varela-Rom\u00e1n A, \u00c1lvarez E, Gonz\u00e1lez-Juanatey JR: Evidence for a role of advanced glycation end products in atrial fibrillation. Int J Cardiol. 2012, 157: 397-402. 10.1016\/j.ijcard.2011.05.072.","journal-title":"Int J Cardiol"},{"key":"908_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/jcph.5","volume":"53","author":"D Kubitza","year":"2013","unstructured":"Kubitza D, Becka M, Roth A, Mueck W: The influence of age and gender on the pharmacokinetics and pharmacodynamics of rivaroxaban\u2013an oral, direct Factor Xa inhibitor. J Clin Pharmacol. 2013, 53: 249-255. 10.1002\/jcph.5.","journal-title":"J Clin Pharmacol"},{"key":"908_CR38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/BF03401779","volume":"6","author":"M Takeuchi","year":"2000","unstructured":"Takeuchi M, Makita Z, Bucala R, Suzuki T, Koike T, Kameda Y: Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo. Mol Med. 2000, 6: 114-125.","journal-title":"Mol Med"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2840-13-60.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T12:39:29Z","timestamp":1630586369000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/1475-2840-13-60"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,13]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["908"],"URL":"https:\/\/doi.org\/10.1186\/1475-2840-13-60","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,13]]},"assertion":[{"value":"12 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"60"}}